Trial Profile
The effect of Suvorexant for migraine attack suppression
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 27 Nov 2015 New trial record